April 28, 2025

Barings Supports Eurazeo’s Investment in Ekoscan

Barings, one of the world’s leading investment managers, today announced its role as co-lender of secured credit facilities supporting Eurazeo on their recent investment in Ekoscan, a leading global provider of advanced ultrasound non-destructive testing solutions. Since 2021, Ekoscan has grown rapidly as a result of 6 strategic acquisitions and impressive organic growth. At present, the Company has 250 employees who serve a loyal and diversified customer base, mainly comprising infrastructure operators.

Founded in 2015, Ekoscan is an end-to-end technology provider of non-destructive testing solutions and services for high value-added inspection in diverse end-markets and geographies. The company focuses on advanced and automated ultrasound testing that allows for preventative, lean, cost-efficient and best-in-class monitoring of clients’ infrastructures. Ekoscan has established industrial partnerships with major players across a broad range of industries.

“We are pleased to support Ekoscan alongside Eurazeo and the management team as the company enters its next phase of growth. This investment highlights Barings’ position as a trusted partner to high quality, resilient businesses delivering mission-critical solutions. We look forward to contributing to the group’s continued success." Gregoire Taillet, Senior Director, Barings Global Private Finance Group

About Barings
Barings is a $442+ billion* global asset management firm (as of March 2025) that partners with institutional, insurance, and intermediary clients, and supports leading businesses with flexible financing solutions. The firm, a subsidiary of MassMutual, seeks to deliver excess returns by leveraging its global scale and capabilities across public and private markets in fixed income, real assets and capital solutions.

*As of March 31, 2025.

About Eurazeo
Eurazeo is a global private equity firm focused on investments in France, UK, other European countries, North America, and Asia. Eurazeo currently manages over €36.1bn in Assets Under Management (as of December 2024). Eurazeo invests in the Small-Mid and Mid-Large buyout segments as well as specialised funds (Growth, Venture, Brands and Healthcare) to support the development of companies in Technology, Business Services, Financial Services, and Healthcare industries.

Important Information

The document is for informational purposes only and is not an offer or solicitation for the purchase or sale of any financial instrument or service in any jurisdiction. The material herein was prepared without any consideration of the investment objectives, financial situation or particular needs of anyone who may receive it. This document is not, and must not be treated as, investment advice, an investment recommendation, investment research, or a recommendation about the suitability or appropriateness of any security, commodity, investment, or particular investment strategy, and must not be construed as a projection or prediction.

In making an investment decision, prospective investors must rely on their own examination of the merits and risks involved and before making any investment decision, it is recommended that prospective investors seek independent investment, legal, tax, accounting or other professional advice as appropriate.

Unless otherwise mentioned, the views contained in this document are those of Barings. These views are made in good faith in relation to the facts known at the time of preparation and are subject to change without notice. Individual portfolio management teams may hold different views than the views expressed herein and may make different investment decisions for different clients. Parts of this document may be based on information received from sources we believe to be reliable. Although every effort is taken to ensure that the information contained in this document is accurate, Barings makes no representation or warranty, express or implied, regarding the accuracy, completeness or adequacy of the information.

This document is issued in Australia by Barings Australia Pty Ltd.